News & Articles
Selected Filters:
Persistent immune memory of COVID-19 found in recovered patient T cells
New research published in Nature Immunology show strong T cell responses in patients recovered from COVID-19
Roche granted FDA clearance for BK virus test to support better care for transplant patients
New test expands Roche molecular test menu for transplant patients, enabling simultaneous testing of BK virus with Cytomegalovirus and Epstein-Barr virus
GSK and Sanofi initiate phase 1/2 clinical trial of COVID-19 adjuvanted recombinant protein-based vaccine candidate
Sanofi and GSK are scaling up the manufacturing of the antigen and adjuvant with the target of producing up to one billion doses in 2021
Sherlock Biosciences announces clinical data from study of Sherlock CRISPR SARS-CoV-2 Kit
Data shows 100% concordance with results from Dartmouth-Hitchcock’s lab-based polymerase chain reaction (PCR) test method
Teknova scales up production of viral transport media to support global response to COVID-19
Rapid increase in production of VTM and saline will help boost virus testing
New tool identifies which cancer patients are most likely to benefit from immunotherapy
A new prognostic tool developed by an international team led by CTI-Bath paves the way for personalized medicine for cancer patients
Fujitsu and Tokyo Shinagawa Hospital to develop an AI-based technology to support COVID-19 diagnosis
The new AI technology will learn from past CT scans of COVID-19 pneumonia patients, reducing the burden on doctors making diagnoses
Roche to launch SARS-CoV-2 Rapid Antigen Test in countries accepting CE mark
Antigen test reliably and quickly triages people suspected of SARS-CoV-2, with results ready in 15 minutes, allowing informed treatment decisions
Micronic offers award-winning recappers to scale-up sample processing
Micronic increases the efficiency of the sample storage or testing process by accelerating the capping and decapping of screw cap tubes
Thirona teams up with Smart Reporting to further improve COVID-19 detection
Combining image analysis with structured reporting, the software aims to improve and accelerate the detection of the virus
Abbott's 15-minute, $5 COVID-19 antigen test receives FDA emergency use authorization
Test delivers results in just 15 minutes with no instrumentation, using proven lateral flow technology with demonstrated sensitivity of 97.1% and specificity of 98.5%
Phase I clinical trial initiated for monoclonal antibody combination for the prevention and treatment of COVID-19
First participants dosed in trial of AZD7442 to assess safety, tolerability and pharmacokinetics of the combination
Fluidigm granted EUA for saliva-based Advanta Dx SARS-CoV-2 RT-PCR assay
The real-time PCR workflow has a capacity of up to 6,000 tests per day per system, and demonstrated 100% agreement with authorized nasopharyngeal assays
QIAGEN expands integrated coronavirus NGS and software solutions
QIAseq SARS-CoV-2 Primer Panel converts viral RNA samples into libraries ready for sequencing, whereas QIAGEN Digital Insights solutions support COVID-19 drug, vaccine and epidemiology research
Luminex files for emergency use of expanded NxTAG Respiratory Panel test
Syndromic testing will streamline respiratory infection diagnosis as COVID-19 pandemic collides with start of flu season
FDA clears AI-based MRI interpretation assistants from Siemens Healthineers
The AI-Rad Companion Brain MR and Prostate MR measures volumetric changes in brain, and segments prostate for targeted biopsy under MRI and ultrasound fusion imaging respectively
Pfizer and BioNTech share positive early data on lead mRNA vaccine candidate against COVID-19
Across all populations, BNT162b2 administration was well tolerated with mild to moderate fever in fewer than 20% of the participants
PerkinElmer launches COVID-19 environmental surface testing kits for food processors
The kits aim to detect traces of SARS-CoV-2 virus on surfaces such as plastics, ceramics and stainless steel
Roche and Regeneron collaborate to increase global supply of REGN-COV2
Regeneron will distribute REGN-COV2 in the U.S. and Roche will be responsible for distribution outside the U.S.
LGC SeraCare SARS-CoV-2 molecular controls kit now CE-marked
The AccuPlex SARS-CoV-2 molecular controls kit is designed to measure day-to-day assay performance and contains positive materials
LGC and Aptahem combine on first large-scale production campaign of Apta-1
The collaboration is the first larger scale production run of Apta-1 as a non-GMP material, intended for use in GLP toxicology studies
Zymo Research granted CE IVD mark for Quick SARS-CoV-2 rRT-PCR kit
The test outperforms other molecular tests with a low detection limit of 15 GEC/reaction (250 GEC/ml of sample) and a robust control system
Bruker supports international COVID-19 NMR consortium on SARS-CoV-2
The consortium aims to determine the dynamics, function and potential for therapeutic intervention of the RNA and protein structures of SARS-CoV-2
Beckman Coulter launches SARS-CoV-2 IgM antibody test and will begin shipping to U.S. diagnostics labs
IgM assay has 95.51% positive predictive value even when disease incidence is only 3%






















